X4 Pharmaceuticals Inc (NAS:XFOR)
$ 1.035 -0.045 (-4.17%) Market Cap: 173.82 Mil Enterprise Value: 157.94 Mil PE Ratio: 0 PB Ratio: 103.50 GF Score: 33/100

Q2 2023 X4 Pharmaceuticals Inc Earnings Call Transcript

Aug 10, 2023 / 12:30PM GMT
Release Date Price: $1.05 (-35.98%)
Operator

Greetings. Welcome to X4 Pharmaceuticals second-quarter 2023 financial and operating results conference call. (Operator Instructions) As a reminder, this conference call is being recorded.

It is now my pleasure to introduce your host, Dan Ferry, from LifeSci Advisors. Please begin.

Dan Ferry
LifeSci Advisors, LLC - IR

Thank you, operator, and good morning, everyone. Presenting on today's call are the X4's Chief Executive Officer, Dr. Paula Ragan; the company's Chief Financial Officer, Adam Mostafa; and Interim Chief Medical Officer, Dr. Murray Stewart. Following prepared remarks by each, we will open the call to your questions. And we'll be joined by Chief Scientific Officer, Art Taveras; Chief Commercial Officer, Mark Baldry; and Chief Operating Officer, Mary DiBiase.

As a reminder, on today's call, the company will be making forward-looking statements regarding regulatory and product development plans, as well as research activities. These statements are subject to risks and uncertainties that may cause actual results to differ from those

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot